Internal influenza viral proteins

Internal influenza viral proteins comprise a group of highly conserved components of the influenza virus, including the nucleoprotein (NP), matrix proteins (M1 and M2), the heterotrimeric polymerase complex (PA, PB1, and PB2), and non-structural proteins such as NS1. Unlike the rapidly evolving surface glycoproteins hemagglutinin and neuraminidase, these internal proteins exhibit high sequence conservation across various influenza A and B strains, making them primary targets for broad-spectrum antivirals and universal vaccine development (NIH, 2023). The NP protein is essential for encapsidating the viral RNA genome, while the M1 protein provides structural support and facilitates viral budding (UniProt, 2024). The M2 protein functions as a proton-selective ion channel required for viral uncoating during entry, and the NS1 protein acts as a potent antagonist of the host's innate immune response (StatPearls, 2023). The polymerase subunits (PA, PB1, PB2) are responsible for the replication and transcription of the viral genome within the host cell nucleus. Therapeutic strategies targeting these proteins include M2 ion channel blockers, PA endonuclease inhibitors, and NP-targeted small molecules, as well as vaccines designed to elicit cross-reactive T-cell responses against conserved internal epitopes (PubMed, 2022).

Other names

Influenza internal antigensConserved influenza proteinsInfluenza core proteinsInfluenza virus internal proteins

Inhibition of M2 ion channel proton transport to prevent viral uncoating; Inhibition of PA subunit cap-dependent endonuclease activity to block viral mRNA synthesis; Inhibition of PB2 subunit cap-binding; Inhibition of RNA-dependent RNA polymerase activity; Inhibition of NP oligomerization and ribonucleoprotein (RNP) assembly; Antagonism of NS1-mediated immune evasion.